Abstract:RationaleTh2 cells play critical roles in the pathogenesis of allergic asthma. Established Th2 cells have been shown to resist reprogramming toward Th1 cells. We sought to understand the mechanisms by which asthmatic CD4+ T cells develop resistance to IL-27-mediated inhibition of Th2 differentiation.MethodsWe isolated and cultured CD4+ T cells from healthy individuals and allergic asthmatic patients and tested whether IL-27 can inhibit IL-4 production by the cultured CD4+ T cells using ELISA. STAT1 phosphorylation was analyzed by Western blot and flow cytometry. Suppressor of cytokine signaling (SOCS) mRNA expressions were measured by qPCR. The siRNA method was used to knockdown SOCS3 mRNA expression.ResultsWe demonstrate that CD4+ T cells from asthmatic patients resisted human IL-27-mediated suppression of IL-4 production. We observed that repeated exposures to Th2-inducing conditions rendered healthy human CD4+ T cells resistant to IL-27-mediated inhibition. Using an in vitro murine culture system, we further demonstrated that repeated or higher doses of IL-4, but not IL-2, stimulation upregulated SOCS3 mRNA expression and impaired IL-27-induced STAT1 phosphorylation. Py-STAT1 expression was impaired in Th2 memory cells circulating in peripheral blood isolated in asthmatics, but not in normal subjects. Knockdown of SOCS3 expression restored IL-27-mediated inhibition.ConclusionsOur findings demonstrate that differentiated Th2 cells can resist IL27-induced reprogramming toward Th1 cells by downregulating STAT1 phosphorylation and upregulation of SOCS3 and may explain why asthmatic CD4+ T cells are resistant to IL-27- mediated differential inhibition. RationaleTh2 cells play critical roles in the pathogenesis of allergic asthma. Established Th2 cells have been shown to resist reprogramming toward Th1 cells. We sought to understand the mechanisms by which asthmatic CD4+ T cells develop resistance to IL-27-mediated inhibition of Th2 differentiation. Th2 cells play critical roles in the pathogenesis of allergic asthma. Established Th2 cells have been shown to resist reprogramming toward Th1 cells. We sought to understand the mechanisms by which asthmatic CD4+ T cells develop resistance to IL-27-mediated inhibition of Th2 differentiation. MethodsWe isolated and cultured CD4+ T cells from healthy individuals and allergic asthmatic patients and tested whether IL-27 can inhibit IL-4 production by the cultured CD4+ T cells using ELISA. STAT1 phosphorylation was analyzed by Western blot and flow cytometry. Suppressor of cytokine signaling (SOCS) mRNA expressions were measured by qPCR. The siRNA method was used to knockdown SOCS3 mRNA expression. We isolated and cultured CD4+ T cells from healthy individuals and allergic asthmatic patients and tested whether IL-27 can inhibit IL-4 production by the cultured CD4+ T cells using ELISA. STAT1 phosphorylation was analyzed by Western blot and flow cytometry. Suppressor of cytokine signaling (SOCS) mRNA expressions were measured by qPCR. The siRNA method was used to knockdown SOCS3 mRNA expression. ResultsWe demonstrate that CD4+ T cells from asthmatic patients resisted human IL-27-mediated suppression of IL-4 production. We observed that repeated exposures to Th2-inducing conditions rendered healthy human CD4+ T cells resistant to IL-27-mediated inhibition. Using an in vitro murine culture system, we further demonstrated that repeated or higher doses of IL-4, but not IL-2, stimulation upregulated SOCS3 mRNA expression and impaired IL-27-induced STAT1 phosphorylation. Py-STAT1 expression was impaired in Th2 memory cells circulating in peripheral blood isolated in asthmatics, but not in normal subjects. Knockdown of SOCS3 expression restored IL-27-mediated inhibition. We demonstrate that CD4+ T cells from asthmatic patients resisted human IL-27-mediated suppression of IL-4 production. We observed that repeated exposures to Th2-inducing conditions rendered healthy human CD4+ T cells resistant to IL-27-mediated inhibition. Using an in vitro murine culture system, we further demonstrated that repeated or higher doses of IL-4, but not IL-2, stimulation upregulated SOCS3 mRNA expression and impaired IL-27-induced STAT1 phosphorylation. Py-STAT1 expression was impaired in Th2 memory cells circulating in peripheral blood isolated in asthmatics, but not in normal subjects. Knockdown of SOCS3 expression restored IL-27-mediated inhibition. ConclusionsOur findings demonstrate that differentiated Th2 cells can resist IL27-induced reprogramming toward Th1 cells by downregulating STAT1 phosphorylation and upregulation of SOCS3 and may explain why asthmatic CD4+ T cells are resistant to IL-27- mediated differential inhibition. Our findings demonstrate that differentiated Th2 cells can resist IL27-induced reprogramming toward Th1 cells by downregulating STAT1 phosphorylation and upregulation of SOCS3 and may explain why asthmatic CD4+ T cells are resistant to IL-27- mediated differential inhibition.

Preventative Administration of Il-27 Improves Airway Inflammation of Ovalbumin - Induced Asthma Mice Model Via Both Stat1 and Gadd45 Gamma/P38mapk Pathways

IL-27 Attenuates Airway Inflammation in a Mouse Asthma Model Via the STAT1 and GADD45γ/p38 MAPK Pathways

Comparison of improvement of two kinds of preventative administration of inter-leukin-27 on airway inflammation and impaired phosphorylation of STAT1 in asthma mice

Intramuscular Delivery of Mil-12 Gene Reduces the Expression of CD44/CD49d on Pulmonary Leucocytes and Inhibits Ovalbumin-Induced Airway Hyperreactivity

Preventative Tracheal Administration of Interleukin-27 Attenuates Allergic Asthma by Improving the Lung Th1 Microenvironment

IL-27 Administration Via Nasal Improves OVA-Induced Airway Inflammation by GADD45ã but Not STAT1 Pathway

Intranasal Administration of IL-27 Pre-OVA Sensitization Alleviate Allergic Airway Inflammation in Mice Model

Altered Frequency of NK Cells and Treg Cells by <i>Astragalus</i> Polysaccharide Combined with Budesonide in Asthma Model Mice

IL-27 Alleviates Airway Inflammation and Airway Hyperresponsiveness in Asthmatic Mice by Targeting the CD39/ATP Axis of Dendritic Cells

The roles of thymic stromal lymphopoietin receptor and its antibody in airway inflammatory response in asthmatic mice

Enhanced Local Foxp3 Expression in Lung Tissue Attenuates Airway Inflammation in A Mouse Model of Asthma

Il-4 Induces Th2 Cells To Resist The Il-27 Counterregulation By Downregulating Stat1 And Stat2 Phosphorylation

Low Doses Of Exogenous Interferon-Gamma Attenuated Airway Inflammation Through Enhancing Fas/Fasl-Induced Cd4(+) T Cell Apoptosis In A Mouse Asthma Model

Inhibition of P21-Activated Kinase 1 Attenuates the Cardinal Features of Asthma Through Suppressing the Lymph Node Homing of Dendritic Cells.

Interferon-γ Stimulates Interleukin-27 Derived from Dendritic Cells to Regulate Th9 Differentiation through STAT1/3 Pathway

Il-25 Promotes Th2 Immunity Responses In Asthmatic Mice Via Nuocytes Activation

Effect of interleukin-15 in pathogenesis of mouse bronchial asthma

IL-25 Promotes Th2 Immunity Responses in Airway Inflammation of Asthmatic Mice Via Activation of Dendritic Cells

Preventive Effect of IL-18 Gene Modified Mature Dendritic Cells Vaccine on Airway Inflammation in Mouse Asthma Model

Impairment of IL-27's Differential Effect on CD4+T Cells in Asthma

Therapeutic effects of anti-B7-1 antibody in an ovalbumin-induced mouse asthma model